Delivery Order SPE2DB24D2018-SPE2DB25FWUL4
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,355.37 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 60 mg. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.56 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 50 mg. The contract has an ultimate completion date of April 30, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,610.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,936,569 units of the prescription medication lisdexamfetamine 10 mg capsules. The contract has an ultimate completion date of April 17, 2025 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6NFB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,428.22 firm fixed-price delivery order is for the supply of 4,568,172,469 units of the prescription medication Lisdexamfetamine 30 mg capsules. The award is not set-aside and has an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,031.80, is a delivery order for the supply of 4,567,202 units of 30 mg Lisdexamfetamine capsules. The contract has a completion date of February 10, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor under this award and has no reported major...
This federal contract award, valued at $1,614.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,489,424 units of the medication lisdexamfetamine 30 mg capsules in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,426.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,073,383 units of the prescription medication Lisdexamfetamine 60 mg capsules. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,151,014 units of the prescription drug Lisdexamfetamine 30 mg capsule. The contract has a ceiling value of $3,726.91 and is a firm-fixed-price delivery order with a completion date of February 3, 2025. The contract is not designated as a set-aside award. AmerisourceBergen Drug...
This federal contract award, with a ceiling value of $3,060.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,250,745 units of the prescription medication lisdexamfetamine 20 mg capsules, with a performance period ending on May 15, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.05 firm fixed-price delivery order is for the supply of 4,567,525,073 units of the drug Lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...